SEC Form 4 · accession 0000357097-16-000202
Fibrocell Science, Inc. · FCSC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Pernock
Officer — Chairman and CEO · Director
Period of report
Dec 2, 2016
Accepted (ET)
Dec 2, 2016 · 11:40 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000357097
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 2, 2016 | P | 50,000 | $0.9217 | A | 105,600 | D |
Table II — derivative securities
No Table II lines on this filing.